ArticleThe Journal of biological chemistry2018

Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.

Qianjin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.